U
UBS Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
1601 |
EFC
1601
Ellington Financial
EFC
$1.38B
|
BV
Brock Vandervliet
| $13.83 | $18.50 |
34%
upside
| Neutral | 4 years ago |
|
1602 |
1602
Equity Lifestyle Properties
ELS
$12B
|
MG
Michael Goldsmith
| $61.72 | $80 |
30%
upside
| Buy | 4 years ago |
|
1603 |
1603
Agilent Technologies
A
$36.5B
|
DB
Dan Brennan
| $128.75 | $152 |
18%
upside
| Buy | 4 years ago |
|
1604 |
1604
Amicus Therapeutics
FOLD
$2.46B
|
EM
Eliana Merle
| $7.99 | $16 |
100%
upside
| Buy | 4 years ago |
|
1605 |
1605
Baidu
BIDU
$35.1B
|
JL
Jerry Liu
| $101.96 | $340 |
233%
upside
| Buy | 4 years ago |
|
1606 |
1606
NetEase
NTES
$85B
| $134.27 | $139 |
4%
upside
| Buy | 4 years ago |
|
|
1607 |
1607
Wells Fargo
WFC
$253B
|
SM
Saul Martinez
| $78.96 | $47 |
40%
downside
| Neutral | 4 years ago |
|
1608 |
1608
Stoke Therapeutics
STOK
$1.13B
|
ER
Esther Rajavelu
| $20.68 | $35 |
69%
upside
| Neutral | 4 years ago |
|
1609 |
1609
First Hawaiian
FHB
$3.21B
|
BV
Brock Vandervliet
| $25.73 | $28 |
9%
upside
| Neutral | 4 years ago |
|
1610 |
1610
Teva Pharmaceuticals
TEVA
$21.7B
|
KC
Kevin Caliendo
| $18.95 | $11 |
42%
downside
| Neutral | 4 years ago |
|
1611 |
1611
Amazon
AMZN
$2.48T
|
ES
Eric Sheridan
| $232.33 | $217.50 |
6%
downside
| Buy | 4 years ago |
|
1612 |
1612
Frontier Group Holdings
ULCC
$1.18B
|
MW
Myles Walton
| $5.18 | $24 |
363%
upside
| Buy | 4 years ago |
|
1613 |
1613
PepsiCo
PEP
$200B
|
SK
Sean King
| $146.39 | $165 |
13%
upside
| Buy | 4 years ago |
|
1614 |
1614
Southern Copper
SCCO
$83.6B
|
AB
Andreas Bokkenheuser
| $102.98 | $62.53 |
39%
downside
| Sell | 4 years ago |
|
1615 |
1615
Thermo Fisher Scientific
TMO
$186B
|
DB
Dan Brennan
| $492.60 | $560 |
14%
upside
| Buy | 4 years ago |
|
1616 |
1616
NiSource
NI
$19B
|
AZ
Aga Zmigrodzka
| $40.33 | $27 |
33%
downside
| Buy | 4 years ago |
|
1617 |
1617
Westlake Chemical Partners
WLKP
$771M
|
SG
Shneur Gershuni
| $21.89 | $25 |
14%
upside
| Neutral | 4 years ago |
|
1618 |
1618
Domo
DOMO
$603M
|
JL
Jennifer Lowe
| $14.62 | $90 |
516%
upside
| Buy | 4 years ago |
|
1619 |
1619
Jazz Pharmaceuticals
JAZZ
$7.86B
|
ER
Esther Rajavelu
| $129.50 | $228 |
76%
upside
| Buy | 4 years ago |
|
1620 |
1620
Icon
ICLR
$13.6B
|
DB
Dan Brennan
| $174.88 | $232 |
33%
upside
| Buy | 4 years ago |
|
1621 |
1621
Snap
SNAP
$12.4B
|
ES
Eric Sheridan
| $7.31 | $85 |
1,063%
upside
| Buy | 4 years ago |
|
1622 |
1622
Vinci Compass Investments Ltd. Class A Common Shares
VINP
$642M
| $10.15 | $26 |
156%
upside
| Buy | 4 years ago |
|
|
1623 |
1623
Vulcan Materials
VMC
$39B
|
NS
Nishu Sood
| $294.81 | $151 |
49%
downside
| Neutral | 4 years ago |
|
1624 |
1624
InMode
INMD
$947M
|
MT
Matthew Taylor
| $14.98 | $42 |
180%
upside
| Buy | 4 years ago |
|
1625 |
1625
Microsoft
MSFT
$3.68T
|
JSL
Jennifer Swanson Lowe
| $495 | $275 |
44%
downside
| Buy | 4 years ago |
|